Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Xerostomia 1Salivary Gland Neoplasms 1Radiation Injuries 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 4Cisplatin 4Gemcitabine 3Carboplatin 3Docetaxel 2Bupropion 2tocilizumab 1tislelizumab 1spartalizumab 1infigratinib 1etoposide phosphate 1cc-486 1avelumab 1Zoledronic Acid 1Vorinostat 1Varenicline 1Tobacco Use Cessation Devices 1Radiotherapy, Intensity-Modulated 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pilocarpine 1Oral Hygiene 1Nivolumab 1Nicotine Replacement Therapy 1Nicotine 1NVP-BKM120 1Ifosfamide 1Gene Expression Profiling 1Fluorouracil 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Nasopharyngeal Neoplasms × Oral Hygiene × Clear all
NCT02589938 2026-02-27

ACUPUNCTURE

Wake Forest University Health Sciences

Phase NA Completed
258 enrolled 16 charts
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡